The PTEN gene helps control how cells grow, divide, and stay alive, and when it does not work properly, cells may keep growing when they should stop. This gene plays an important role in keeping growth signals balanced, like a brake that helps prevent tissue overgrowth. Pathogenic variants in the PTEN gene can cause a condition called PTEN hamartoma tumor syndrome, which may include a larger head size, noncancerous growths, and a higher chance of certain cancers. PTEN is also well known in cancer research because loss of its function is common in many tumors.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they happen, and how strongly they take place. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a deeper look at this topic, you can find more in the LearnHub.
Overview
PTENGene function
What if the gene works
The PTEN gene helps control when cells grow, divide, and survive. It acts like a brake on cell signaling, helping tissues develop normally and limiting extra cell growth.
Risk
What if the gene does not work
Variants in the PTEN gene can cause PTEN hamartoma tumor syndrome, ranging from milder to more severe forms. Common features include large head size, benign tissue overgrowth, developmental differences, and increased risks of several cancers.
Treatment
What does that mean for your treatment
No PTEN-specific treatment or drug choice is currently established for people with a pathogenic variant in the PTEN gene. PTEN loss is being studied as a biomarker for some targeted cancer drugs, especially those aimed at cell growth signaling pathways.
Conditions associated with PTEN
Gene function
What if the gene works
The PTEN gene helps your cells balance growth with restraint. When it is working normally, cells respond to everyday growth signals in a measured way and stay organized within tissues. Understanding the PTEN gene's function helps explain how healthy tissues maintain that balance over time.
The PTEN gene removes a small chemical tag from a messenger at the cell membrane. This turns down growth signals so cells react in a more controlled way.
By easing overly strong go signals, this gene helps cells grow at a pace that fits the body's needs. This supports normal tissue upkeep in places where cells are regularly replaced.
The PTEN gene helps coordinate when cells move forward with division. This keeps routine renewal more orderly, such as when skin or gut lining cells are replaced.
This gene also supports how cells keep their shape, position, and contact with nearby cells. This helps tissues stay structured and layered in a stable way.
What is a variant?
A genetic variant is a slight change in the DNA sequence of a gene. These changes are common and help account for normal differences among people, such as appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, however, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
PTEN gene variants can weaken or shut down the protein by changing its shape, shortening it, making it unstable, or keeping it from reaching the right part of the cell membrane. In plain terms, what happens when the PTEN gene does not work properly depends on the variant: some milder changes leave partial activity, while more disruptive variants can lead to little or no working protein. That difference can influence how strongly cell growth signals escape normal control and, in PTEN-related conditions, may affect how early or clearly features appear.
How variants are linked to conditions
Pathogenic variants in the PTEN gene cause PTEN hamartoma tumor syndrome, which includes Cowden syndrome and related conditions. PTEN gene variants are linked to higher lifetime chances of breast, thyroid, endometrial, kidney, colorectal, and some skin cancers. Some people also have a large head size, noncancerous growths, or developmental differences, including autism or developmental delay.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, particularly when several genes and environmental influences play a role. Still, in some situations, one well described variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with a harmful change in the PTEN gene, much of the risk is driven by the variant itself, with risk often changing by age, sex, and family history. There is not enough evidence to say lifestyle changes lower this inherited risk, so regular cancer screening and follow-up are the most important steps.
Inheritance of PTEN variants
PTEN-related conditions are usually inherited in an autosomal dominant pattern, which means a person with a PTEN gene variant has a 50% chance of passing it on to each child. This is the key point in understanding how PTEN variants are inherited in families. Males and females are equally likely to inherit or pass on the variant. Some people have a new, de novo PTEN gene variant that was not inherited from either parent.
What does my PTEN result mean for my family?
A harmful change in the PTEN gene often means close relatives, like parents, brothers, sisters, and children, may also carry the same change and could share a higher chance of related health problems, including certain growths and cancers. Because this pattern is usually passed down in families in a dominant way, each child of someone with a PTEN change can inherit it. The family impact depends on the exact result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the PTEN gene, genetic testing for PTEN variants usually uses a blood or saliva sample. A lab reads the DNA code in the PTEN gene and reports whether a variant was found and whether it is linked to health risk.
When should I consider getting a genetic test?
PTEN genetic testing may be worth considering if you or close relatives have a pattern of certain cancers, especially breast, thyroid, uterine, or kidney cancer, or many noncancerous growths and a very large head size. It can also be considered in children with developmental delay or autism plus a larger-than-usual head.
A genetic result is only one part of your health story
Genetic results can offer useful insight, but how much they reveal varies by the condition and the type of variant involved. Over time, the way the body works is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, from how quickly a drug is broken down to how strongly it works at its target. That helps explain why the same treatment may work well for one person but cause more side effects or less benefit in another. These differences are common and can influence both how effective a medicine is and how sensitive someone is to it. Genes are only part of the picture, and age, overall health, and other medicines also play a role.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how genetic differences affect the way people respond to medications. It examines relationships between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can help guide treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the PTEN gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in routine drug prescribing, so questions about medicines, side effects, or treatment changes are best discussed with your doctor. PTEN has been studied in cancer care because changes in PTEN may influence how some tumors respond to certain targeted treatments, but this is usually considered by cancer specialists rather than used as a standard prescribing guide.
History
In the 1990s, researchers searching for missing pieces in cancer genetics identified the PTEN gene on chromosome 10. In 1997, several groups independently described it as an important tumor suppressor gene, marking a major step in understanding how inherited and acquired gene variants can contribute to cancer. Building on this early work, scientists also connected harmful variants in the PTEN gene with Cowden syndrome and related PTEN hamartoma tumor syndrome conditions. That link helped explain why some families developed characteristic growths and a higher chance of certain cancers across generations. Over time, descriptions became more precise as genetic testing improved and doctors recognized a wider range of PTEN related features. Today, the PTEN gene is well known in cancer genetics because its discovery helped shape modern inherited cancer care.